| Judul | Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers / Veysel Kayser (editor) |
| Pengarang | Kayser, Veysel (editor) |
| Penerbitan | Basel, Switzerland : MDPI Books, 2022 |
| Deskripsi Fisik | 300p :ill |
| ISBN | 978-3-0365-2686-7 |
| Subjek | DRUGS--DESIGN PHARMACEUTICAL CHEMISTRY |
| Abstrak | The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody–Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from academia and industry. The book should be of interest to those scientists and researchers who develop or use biologics, biotherapeutics, biosimilars and biobetters in cancer treatment. |
| Bentuk Karya | Tidak ada kode yang sesuai |
| Target Pembaca | Tidak ada kode yang sesuai |
| Lokasi Akses Online |
https://mdpi-res.com/bookfiles/book/4898/Therapeutic_Monoclonal_Antibodies_and_Antibody_Products_Their_Optimization_and_Drug_Design_in_Cancers.pdf?v=1765245947 |
| No Barcode | No. Panggil | Akses | Lokasi | Ketersediaan |
|---|---|---|---|---|
| 550525192 | 615.798 Kay t | Baca Online | Perpustakaan Pusat - Online Resources ** Tidak Diketahui *** |
Tersedia |
| Tag | Ind1 | Ind2 | Isi |
| 001 | INLIS000000000165524 | ||
| 005 | 20251209115252 | ||
| 007 | ta | ||
| 008 | 251209################|##########|#|## | ||
| 020 | # | # | $a 978-3-0365-2686-7 |
| 035 | # | # | $a 0010-1225000169 |
| 082 | # | # | $a 615.798 |
| 084 | # | # | $a 615.798 Kay t |
| 100 | 0 | # | $a Kayser, Veysel (editor) |
| 245 | 1 | # | $a Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers /$c Veysel Kayser (editor) |
| 260 | # | # | $a Basel, Switzerland :$b MDPI Books,$c 2022 |
| 300 | # | # | $a 300p : $b ill |
| 520 | # | # | $a The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody–Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from academia and industry. The book should be of interest to those scientists and researchers who develop or use biologics, biotherapeutics, biosimilars and biobetters in cancer treatment. |
| 650 | # | # | $a DRUGS--DESIGN |
| 650 | # | # | $a PHARMACEUTICAL CHEMISTRY |
| 856 | # | # | $a https://mdpi-res.com/bookfiles/book/4898/Therapeutic_Monoclonal_Antibodies_and_Antibody_Products_Their_Optimization_and_Drug_Design_in_Cancers.pdf?v=1765245947 |
| 990 | # | # | $a 550525192 |
Content Unduh katalog
Karya Terkait :